A dual function TB subunit vaccine designed for non-interference with BCG and post-exposure activity

Ended Project Grant Awarded Last action

Award ID
R01AI135721
Recipient
Awarding agency
Obligated
$6,447,137

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Originally
Funding
  • $5,291,546.00 Federal
  • $1,155,591.00 Non-federal
Place of performance
Denmark

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $647,855 $0
Amendment $647,855 $0
Amendment $1,155,591 $0
Amendment $1,155,591 $1,155,591
Amendment $0 $0
Amendment $0 $0
Amendment $94,907 $0
Amendment $670,614 $0
Amendment $642,131 $0
Original award $277,002 $0
Show all 11

Quick answers

Who received award R01AI135721?

R01AI135721 was awarded to Statens Serum Institut by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on December 1, 2017.

How much is award R01AI135721 worth?

$6,447,137 has been obligated on R01AI135721: $5,291,546 in federal funding and $1,155,591 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award